Daily non-political popular news in brief.

Treatment extends survival in mouse model of spinal muscular atrophy

Drug therapy can extend survival and improve movement in a mouse model of spinal muscular atrophy (SMA), new research shows. The study, carried out at the NIH's National Institute of Neurological Disorders and Stroke (NINDS), suggests that similar drugs might one day be useful for treating human SMA.

Read more »

Keywords: treatment, extends, survival, mouse, model, spinal, muscular, atrophy, extend

« Previous | Next »

Similar news on "Treatment extends survival in mouse model of spinal muscular atrophy":

1. Drug blocks lethal motor-neuron disease in mice
   02-22-2007 · EurekAlert!
   Spinal muscular atrophy (SMA) is a motor-neuron disease caused by mutations in the gene SMN1 that prevent it producing the protein SMN. New research shows that in a lethal mouse model of SMA the drug trichostatin A (TSA), which is a hydroxamic acid HDAC inhibitor, can improve survival and attenuate disease, indicating that hydroxamic acid HDAC inhibitors might be potential therapeutics for the treatment of individuals with SMA.
   Similar news · Read more »
   
2. Molecular medical research points to treatment of spinal muscular atrophy
   11-02-2007 · EurekAlert!
   Researchers at the Peninsula Medical School in Exeter, UK, have carried out studies into one of the two survival motor neuron genes that set suffers from SMA apart from the rest of the population.
   Similar news · Read more »
   
3. UD researchers discover technique for repairing gene defect that causes spinal muscular atrophy
   02-11-2008 · EurekAlert!
   Researchers at the University of Delaware have discovered a novel technique -- that acts like a "spell-checker" for correcting a misspelling in the DNA code -- to repair the defective gene that causes spinal muscular atrophy. This hereditary neuromuscular disease is the number-one genetic killer of children under two years old.
   Similar news · Read more »
   
4. New insight about the source of anxiety in Rett syndrome
   11-13-2006 · EurekAlert!
   A peptide known to play a role in anxiety is overly plentiful in a mouse model of the inherited neurological disorder Rett syndrome and appears to underlie the anxiety-like behavior in these mice. The finding could provide a clue to treatment for this symptom.
   Similar news · Read more »
   
5. New research disproves belief that group psychotherapy extends the lives of cancer patients
   05-01-2007 · EurekAlert!
   Previously-published research has given credence to the notion that psychotherapy extends the lives of people with cancer. In fact, one in four cancer patients believe that science supports the idea that participating in group therapy will extend their lives. However, researchers as the University of Pennsylvania School of Medicine concluded -- after an extensive research review -- that there is no compelling evidence linking psychotherapy or support groups with survival among cancer patients.
   Similar news · Read more »
   
6. Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
   06-01-2007 · EurekAlert!
   Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a rare, degenerative muscle disease. In an unexpected finding, the research indicates that the approach also might benefit patients with certain kidney disorders.
   Similar news · Read more »
   
7. Study demonstrates improved health, survival in aged overweight male mice on resveratrol
   11-01-2006 · EurekAlert!
   A natural compound found in plants protected aged mice from the negative effects of a high calorie diet, according to a new mouse study by the National Institute on Aging and others. Previous studies of resveratrol, a small molecule produced by certain plants in response to stress, found that the compound can extend lifespan in yeast, worms, flies and fish.
   Similar news · Read more »
   
8. Common blood pressure drug reduces progressive muscle degeneration in mice
   02-02-2007 · EurekAlert!
   Scientists supported in part by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Institute of Neurological Disorders and Stroke (NINDS) have found that that the commonly prescribed blood pressure medication losartan improves muscle regeneration and repair in a mouse model of Duchenne muscular dystrophy (DMD), a devastating disease characterized by rapid progression of muscle degeneration in boys and young men.
   Similar news · Read more »
   
9. St. Jude announces breakthrough in eye cancer treatment
   11-01-2006 · EurekAlert!
   Scientists at St. Jude Children's Research Hospital have demonstrated in a mouse model a new, locally applied treatment for the eye cancer retinoblastoma that not only greatly reduces the size of the tumor, but does so without causing the side effects common with standard chemotherapy.
   Similar news · Read more »
   
10. News tips from the Journal of Neuroscience
    07-17-2007 · EurekAlert!
    In this issue: BMP signaling and synaptic plasticity, Reducing oligodendrocyte apoptosis after spinal cord injury, News for the left-handed, and The benefits of sleep in a mouse model of HD.
    Similar news · Read more »